期刊文献+

冠脉内支架植入术后患者生存质量及影响因素研究 被引量:6

Study on Quality of Life and Influencing Factors in Patients after Coronary Stent Implantation
下载PDF
导出
摘要 目的了解冠脉内支架植入术后患者的生存质量状况,分析生存质量的相关影响因素。方法采用SF-36量表及自行设计的问卷,对125例冠脉内支架植入术后的患者进行调查。结果SF-36量表8个维度即生理功能、生理职能、躯体疼痛、总体健康、精力、社会功能、情感职能、精神健康的得分分别为:(72.74±16.05)分、(47.15±33.55)分、(66.27±20.39)分、(55.78±19.88)分、(66.75±17.5)2分、(69.74±21.30)分、(65.49±34.33)分、(70.31±14.54)分;多个维度得分低于四川一般人群;影响冠脉内支架植入术后患者生存质量的因素主要有心绞痛发作频率、锻炼、睡眠质量、年龄、经济状况、社会支持。结论随着冠脉内支架植入术的广泛开展,应采取综合性的干预措施提高这些患者的生存质量。 Objective To investigate the quality of life in patients after coronary stent implantation,and analyze the factors associated with quality of life. Methods Questionnaires were sent to 125 patients after coronary stent implantation. The survey instruments included Short Form 36 Health Survey Questionnaire and Questionnaire designed by the investigator. Results The score of eight domains, namely Physical Functioning, Role-Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role-Emotional, Mental Health of SF-36 in the sampled patients were 72.74±16.05,47.15±33.55,66.27±20.39,55.78±19.88,66.75±17.52,69.74±21.30,65.49±34.33,70.31±14.54 respectively. Compared with the general population in Sichuan,the scores of most domains in the patients were lower. Angina,physical exercise,sleep quality,age,economic status and social support were main influencing factors to affect the different aspects of the life quality of patients after coronary stenting. Conclusion With an increasing number of coronary stenting procedures performed each year,it is essential to take comprehensive measures should be strengthened.
出处 《中国现代医生》 2008年第36期18-19,38,共3页 China Modern Doctor
关键词 冠脉内支架植入 生存质量 影响因素 Coronary stent implantation Quality of life Influencing factors
  • 相关文献

参考文献7

二级参考文献15

  • 1国家统计局人口与就业司.中国人口统计年鉴[M].北京:中国统计出版社,1997.4-6. 被引量:2
  • 2国家统计局人口与就业司,中国人口统计年鉴,1997年,4页 被引量:1
  • 3Acquadro C, Jambon B, Ellis D, et al. Language and translation issues. In: Spilker B,ed. 2nd. Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott, 1996.575-585. 被引量:1
  • 4Calverley P, Pauwels R, Vestbo J, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.Lancet,2003,361:449-456. 被引量:1
  • 5高润霖.中国冠心病介入冶疗现状.中国医学论坛报,2003-11-20(2). 被引量:1
  • 6van Domburg RT, Lemos PA,Takkenberg JM, et al. The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease. Eur Heart J,2005,26:675-681. 被引量:1
  • 7中华人民共和国卫生部.中国卫生统计提要.2005. 被引量:1
  • 8Cook S, Togni M, Walpoth N, et al. Percutaneous Coronary Interventions in Europe 1992-2003. Eurolnterv,2006,1:374-379. 被引量:1
  • 9Jensen LO, Maeng MI, Thayssen P, et al. Impact of drug eluting stents on target vessel revascularization. A report from the western Denmark heart registry from 2000 to 2004. Eurolnterv, 2006,1:391-395. 被引量:1
  • 10Nagle PC, Smith AW. Review of recent US cost estimates of revascularization. Am J Manag Care, 2004,10:S370-S376. 被引量:1

共引文献538

同被引文献70

引证文献6

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部